All In Biotech

Drug Trial Radar · NCT00732849

The Impact of the Type and Route of Nutritional Support on Infectious Complications After Upper Gastrointestinal Surgery

The Impact of the Type and Route of Nutritional Support on Infectious Complications After Upper Gastrointestinal Surgery - A Prospective, Randomized, Clinical Trial.

Last checked: Nov 20, 2026Latest source record: Aug 12, 2008 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 600 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

600

Actual

Start

Jun 2002

Primary completion

Sep 2002

Study completion Nov 2007

Sponsor

Lead sponsor
Jagiellonian UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 12, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Treatment
Who can join
All sexes
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The study was designed to test the hypothesis that immunonutrition and enteral nutrition would reduce the incidence of infectious complications in a population of malnourished patients following elective upper GI surgery

Conditions

  • Gastrointestinal Surgery

Interventions

  • Reconvan, Dipeptiven, OmegavenDrug

    Reconvan (1ml=1 kcal), 30 kcal/kg b.w. Omegaven 1 ml/ kg b.w. Dipeptiven 1 ml/ kg b.w.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Immunonutrition and enteral nutrition would reduce the incidence of infectious complications in a population of malnourished patientsTime frame: Immunonutrition

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • 1st Department of SUegy

    Krakow, _30978, Poland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.